KR100486320B1 - Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one - Google Patents

Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one Download PDF

Info

Publication number
KR100486320B1
KR100486320B1 KR10-2002-0039111A KR20020039111A KR100486320B1 KR 100486320 B1 KR100486320 B1 KR 100486320B1 KR 20020039111 A KR20020039111 A KR 20020039111A KR 100486320 B1 KR100486320 B1 KR 100486320B1
Authority
KR
South Korea
Prior art keywords
dibenz
compound
reaction
formula
dihydro
Prior art date
Application number
KR10-2002-0039111A
Other languages
Korean (ko)
Other versions
KR20040004891A (en
Inventor
서명원
Original Assignee
일동제약주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 일동제약주식회사 filed Critical 일동제약주식회사
Priority to KR10-2002-0039111A priority Critical patent/KR100486320B1/en
Publication of KR20040004891A publication Critical patent/KR20040004891A/en
Application granted granted Critical
Publication of KR100486320B1 publication Critical patent/KR100486320B1/en

Links

Classifications

    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01HELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H85/00Protective devices in which the current flows through a part of fusible material and this current is interrupted by displacement of the fusible material when this current becomes excessive
    • H01H85/02Details
    • H01H85/30Means for indicating condition of fuse structurally associated with the fuse
    • HELECTRICITY
    • H01ELECTRIC ELEMENTS
    • H01HELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
    • H01H85/00Protective devices in which the current flows through a part of fusible material and this current is interrupted by displacement of the fusible material when this current becomes excessive
    • H01H85/02Details
    • H01H85/20Bases for supporting the fuse; Separate parts thereof
    • H01H2085/2075Junction box, having holders integrated with several other holders in a particular wiring layout
    • H01H2085/208Junction box, having holders integrated with several other holders in a particular wiring layout specially adapted for vehicles

Abstract

본 발명에서는 다음 구조식 (VI)의 화합물을 반응 촉매로 요오드산과 적린을 사용하고 초산을 반응 용매로 사용하여 환원 반응을 시키는 것으로 이루어진 다음 구조식 (I)의 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온의 제조방법을 제공한다.In the present invention, 5,11-dihydro-6H-dibenz of the following formula (I) consisting of the reaction of the compound of the formula (VI) using a iodic acid and red phosphorus as a reaction catalyst, and the acetic acid as a reaction solvent Provided are methods for preparing [b, e] azin-6-one.

본 발명에 따라 제조된 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온는 항히스타민제를 비롯한 의약품 제조에 유용한 중간체 화합물이다.The 5,11-dihydro-6H-dibenz [b, e] azin-6-ones prepared according to the present invention are useful intermediate compounds for the manufacture of pharmaceuticals, including antihistamines.

Description

5,11-디히드로-6에이치-디벤즈[비,이]아제핀-6-온의 제조방법 {Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one}Preparation method of 5,11-dihydro-6H-dibenz [B, I] azepin-6-one {Preparation method of 5,11-dihydro-6H-dibenz [b, e] azepin-6-one}

본 발명은 의약품등의 제조에 사용되는 다음 구조식 (I)의 화합물인 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온 (또는 5,6-디히드로-6-옥소모판트리딘)을 제조하는 신규 방법에 관한 것이다.The present invention provides 5,11-dihydro-6H-dibenz [b, e] azin-6-one (or 5,6-dihydro-6) which is a compound of formula (I) -Oxomopantridine).

[화학식 1][Formula 1]

상기 구조식 (I)의 화합물은 항히스타민제인 3-아미노-9,13b-디히드로-1H-디벤즈[c,f]이미다조[1,5-a]아제핀 히드로클로라이드를 비롯한 각종 의약품 합성을 위한 중간체로 유용하다. 이에, 상기 구조식 (I)의 화합물의 제조방법에 대한 다양한 연구가 진행되어 왔다. The compound of formula (I) is used for the synthesis of various pharmaceuticals, including the antihistamine 3-amino-9,13b-dihydro-1H-dibenz [c, f] imidazo [1,5-a] azepine hydrochloride. Useful as an intermediate. Accordingly, various studies on the preparation method of the compound of formula (I) have been conducted.

상기 구조식 (I)의 화합물의 일반적인 제조방법은 Indian J. Chem. 23B, 165(1984), 독일특허 제2431409호, 미국특허 제3367930호, 독일특허 제2505714호 및 미국특허 제3910890호 등에 기술되어 있다. 이들 공지의 제조방법에 기술된 구조식 (I)의 대표적인 제조방법은 다음과 같이 세 가지로 나눌 수 있다.A general method for preparing the compound of formula (I) is Indian J. Chem. 23B, 165 (1984), German Patent No. 2431409, US Patent No. 3367930, German Patent No. 2505714, US Patent No. 3910890, and the like. Representative production methods of formula (I) described in these known production methods can be divided into three types as follows.

첫 번째, 구조식 (II)의 화합물을 베크만 전위반응시켜 목적화합물 (I)의 화합물을 제조하는 방법과First, the method of preparing the compound of the target compound (I) by Beckman potential reaction of the compound of the formula (II) and

[반응식 1]Scheme 1

두 번째, 구조식 (III)의 화합물을 포스겐과 반응하여 구조식 (IV)를 제조한 후 알루미늄 클로라이드를 촉매로 사용하여 목적화합물 (I)을 제조하는 방법과 Secondly, to prepare the desired compound (I) by reacting the compound of formula (III) with phosgene to produce formula (IV) and then using aluminum chloride as a catalyst;

[반응식 2]Scheme 2

세 번째, 구조식 (V)의 화합물을 벤젠 용매하에서 불산 또는 알류미늄클로라이드와 반응시켜 목적화합물 (I)을 제조하는 방법이 공지되어 있다.Third, a method for preparing the desired compound (I) by reacting the compound of formula (V) with hydrofluoric acid or aluminum chloride in a benzene solvent is known.

[반응식 3]Scheme 3

그러나 이들 방법 중 첫 번째 방법인 베크만 전위반응을 이용한 구조식 (II)의 화합물로부터 목적화합물 (I)의 합성은 실제로는 거의 일어나지 않는다. 또한 두 번째 방법인 구조식 (III)의 화합물로부터 구조식 (IV)를 제조하는 방법은 강한 독성을 가진 화합물인 포스겐을 사용하여야만 하므로 매우 위험한 공정이다. 또한 출발물질로 사용되는 화합물 (III)는 여러 단계의 공정을 거쳐 제조해야만 하는 난점이 있다. 세 번째로 구조식 (V)의 화합물로부터 구조식 (I)의 화합물을 제조하는 방법 역시 출발물질인 구조식 (V)의 화합물은 독성이 강한 포스겐을 사용하여 제조해야 하며, 반응에 있어서도 독성이 강한 벤젠을 용매로 사용하고, 부식성이 강한 불산을 사용하는 등 여러 가지 단점을 가지고 있다. However, the synthesis of the target compound (I) from the compound of formula (II) using the Beckman potential reaction, which is the first of these methods, hardly occurs. In addition, the second method of preparing the formula (IV) from the compound of the formula (III) is a very dangerous process because it requires the use of phosgene, a compound with strong toxicity. In addition, compound (III), which is used as a starting material, has to be prepared through a multi-step process. Third, the method of preparing the compound of formula (I) from the compound of formula (V) should also be prepared using the toxic phosgene, which is also a starting material, and the highly toxic benzene in the reaction. It has various disadvantages such as using as a solvent and using highly corrosive hydrofluoric acid.

또한, 11-히드록시-5,11디히드로-디벤즈[b,e]아제핀-6-온을 요오드산과 초산을 이용하여 목적하는 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 제조하는 방법이 공지되어있다(Can. J. Chem. 1994, 72(2), 334). 하지만 그 출발물질인 11-히드록시-5,11디히드로-디벤즈[b,e]아제핀-6-온은 본 발명자가 출발물질로 사용한 5H-디벤즈[b,e]아제핀-6,11-디온을 소디움보로히드라이드을 사용하여 환원하여 제조하므로 두 번의 반응 공정을 거치게 되므로 공정이 길고 수율이 낮아지므로 비경제적이다. 또한 환원제인 소디움보로히드라이드는 반응시에 위험한 수소가스가 발생하므로 취급에 어려움이 있다. In addition, 11-hydroxy-5,11 dihydro-dibenz [b, e] azepin-6-one was converted into the desired 5,11-dihydro-6H-dibenz [b, e using iodic acid and acetic acid. ] Methods for preparing azepin-6-one are known (Can. J. Chem. 1994, 72 (2), 334). However, the starting material, 11-hydroxy-5,11dihydro-dibenz [b, e] azepin-6-one, was used as the starting material by the present inventors, 5H-dibenz [b, e] azepine-6. Since, 11-dione is prepared by reduction using sodium borohydride, it is uneconomical because the process is long and the yield is low because the reaction is performed twice. In addition, sodium borohydride, a reducing agent, is difficult to handle because it generates dangerous hydrogen gas during the reaction.

통상적으로 디아릴케톤의 환원은 울프-키쉬너 환원반응, 클레멘센 환원반응 및 강력한 환원시약인 라이니-니켈, 또는 리튬알루미늄히드라이드 등을 이용한 환원반응을 사용하지만 본 발명자들이 출발물질로 이용한 5H-디벤즈[b,e]아제핀-6,11-디온 화합물과 상기의 반응방법들에서는 만족할만한 수율과 효과를 얻지 못했다. In general, the reduction of the diaryl ketone uses a Wolf-Kishner reduction reaction, a clemencene reduction reaction, and a reduction reaction using a strong reducing reagent such as Lyni-nickel or lithium aluminum hydride, but the inventors used 5H as a starting material. Dibenz [b, e] azepine-6,11-dione compounds and the above reaction methods did not yield satisfactory yields and effects.

요오드산과 적린을 이용한 아릴케톤의 환원반응은 안트라센 구조의 화합물 합성에 이용된 경우는 보고 되어 있으나 이와 같은 아미드관능기가 있는 아제핀 구조의 화합물 합성에 응용된 보고는 없다.Reduction of aryl ketones using iodic acid and red phosphorus has been reported to be used for the synthesis of anthracene structures, but there have been no reports applied to the synthesis of azepine structures with such amide functional groups.

본 발명에서는 목적 화합물을 합성하는데 있어 공지방법의 단점인 긴 반응공정과 낮은 수율과 독성 및 부식성이 강한 화합물의 사용 등의 여러 가지 문제점을 해결하고 단순한 반응 공정과 온화하고 용이한 반응 조건에서 높은 수율과 순도로서 목적화합물을 제조하는 방법을 제공하는데 그 목적이 있다. The present invention solves various problems such as long reaction process, low yield and use of highly toxic and corrosive compounds, which are disadvantages of known methods in synthesizing the target compound, and high yield under simple reaction process and mild and easy reaction conditions. Its purpose is to provide a method for preparing the target compound with high purity.

본 발명은 5H-디벤즈[b,e]아제핀-6,11-디온 화합물 (VI)를 출발물질로 하여 환원반응을 통하여 목적 화합물 (I)을 제조하는 것을 특징으로 한다.The present invention is characterized in that the target compound (I) is prepared through a reduction reaction using 5H-dibenz [b, e] azepine-6,11-dione compound (VI) as a starting material.

본 발명을 보다 구체적으로 설명하면 다음과 같다.The present invention will be described in more detail as follows.

본 발명은 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 제조하는데 있어 [반응식 4]에 나타낸 바와 같이 5H-디벤즈[b,e]아제핀-6,11-디온을 출발물질로 사용하여 초산 용매와 요오드산과 적린을 사용하여 환원반응을 통해 목적화합물 (I)을 얻을 수 있다. The present invention relates to the preparation of 5,11-dihydro-6H-dibenz [b, e] azepin-6-one as shown in Scheme 4 as shown in Scheme 4 The target compound (I) can be obtained through reduction reaction using acetic acid solvent, iodic acid and red phosphorus using, 11-dione as starting material.

여기에서 5H-디벤즈[b,e]아제핀-6,11-디온은 공지의 물질이며, 공지의 합성방법 [J. Med. Chem. 1965, 8, 74. 등]을 이용하여 손쉽게 얻을 수 있다.Wherein 5H-dibenz [b, e] azepine-6,11-dione is a known substance and known synthetic methods [J. Med. Chem. 1965, 8, 74., etc.].

본 반응에서 환원 반응의 촉매로는 요오드산과 적린을 사용하였으며, 요오드산의 당량은 구조식 (VI)의 화합물을 기준으로 1.0 내지 20.0 당량을 사용하였으며 바람직하게는 2.0 당량 전후이다. 또한 적린의 당량은 구조식 (VI)의 화합물을 기준으로 1.0 내지 20.0 당량을 사용하였으며 바람직하게는 1.1 당량 전후이다. 반응 용매로는 초산을 사용한다. 반응 온도는 상온 내지 환류온도이고, 바람직하게는 100℃에서 120℃정도이다. 반응 시간은 1시간에서 48시간, 바람직하게는 12시간에서 20시간 정도이다.In the present reaction, iodic acid and red phosphorus were used as catalysts for the reduction reaction, and an equivalent amount of iodic acid was used in an amount of 1.0 to 20.0 equivalents based on the compound of formula (VI), and preferably around 2.0 equivalents. In addition, the equivalent amount of red phosphorus was 1.0 to 20.0 equivalents based on the compound of the formula (VI), preferably about 1.1 equivalents. Acetic acid is used as the reaction solvent. The reaction temperature is from room temperature to reflux temperature, preferably from 100 ° C to 120 ° C. The reaction time is about 1 hour to 48 hours, preferably about 12 hours to 20 hours.

[반응식 4]Scheme 4

이하 본 발명을 다음의 실시예에 의거하여 더욱 상세히 설명하는 바, 본 발명이 이에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.

[참고 실시예 1]Reference Example 1

5H-디벤즈[b,e]아제핀-6,11-디온의 합성Synthesis of 5H-dibenz [b, e] azepine-6,11-dione

20.0g(96mmol)의 안트라퀴논을 120ml의 황산과 30ml의 클로로포름에 용해시키고, 반응 혼합물을 0℃로 냉각시켰다. 8.8g(0.135mol)의 소디움아지드를 반응 혼합물에 10℃이하의 온도를 유지하면서 나누어 가하고, 실온에서 12시간동안 교반하면서 반응시켰다. 1L의 얼음물에 반응액을 가하여 결정을 생성시키고 실온에서 1시간동안 추가 교반 후, 생성된 결정성 화합물을 여과하고 물로 여러 번 세척하여 흰색의 목적화합물을 얻었다. 목적화합물을 21.1g의 수율(이론치의 98%)로 수득하였다.20.0 g (96 mmol) of anthraquinone was dissolved in 120 ml of sulfuric acid and 30 ml of chloroform and the reaction mixture was cooled to 0 ° C. 8.8 g (0.135 mol) of sodium azide were added in portions to the reaction mixture while maintaining the temperature below 10 ° C, and reacted with stirring at room temperature for 12 hours. The reaction solution was added to 1 L of ice water to form crystals. After further stirring at room temperature for 1 hour, the resulting crystalline compound was filtered and washed several times with water to obtain a white target compound. The desired compound was obtained in a yield of 21.1 g (98% of theory).

융점 : 246~248℃ Melting Point: 246 ~ 248 ℃

IR cm-1(KBr) : 3190, 3030, 2980, 2910, 1660, 1650, 1580, 1560, 1480, 1430, 1390, 1300, 1233, 1160IR cm -1 (KBr): 3190, 3030, 2980, 2910, 1660, 1650, 1580, 1560, 1480, 1430, 1390, 1300, 1233, 1160

1H-NMR(DMSO-d6) : δ(ppm) 7.22(t, 1H, J=7.9Hz), 7.34(d, 1H, J=8.0Hz), 7.58(t, 1H, J=7.7Hz), 7.71(d, 1H, J=1.9Hz), 7.69~7.85(m, 3H), 8.17(m, 1H), 11.1(s, 1H) 1 H-NMR (DMSO-d 6 ): δ (ppm) 7.22 (t, 1H, J = 7.9 Hz), 7.34 (d, 1H, J = 8.0 Hz), 7.58 (t, 1H, J = 7.7 Hz) , 7.71 (d, 1H, J = 1.9 Hz), 7.69-7.85 (m, 3H), 8.17 (m, 1H), 11.1 (s, 1H)

[실시예 1]Example 1

5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온의 합성Synthesis of 5,11-dihydro-6H-dibenz [b, e] azin-6-one

10.0g (44.8mmol)의 5H-디벤즈[b,e]아제핀-6,11-디온을 50ml의 초산에 녹인 후 1.5g (48.4mmol)의 적린과 15ml의 57% 요오드산을 넣고 18시간동안 환류 교반하였다. 실온까지 방냉 후 7g의 아황산수소나트륨이 용해된 300ml의 얼음물을 반응 혼합물에 붓고 교반 후, 300ml의 클로로포름을 가한 후 강력하게 교반하고, 유기층을 분리한 후 탄산수소나트륨이 포화된 수용액으로 세척하고, 무수황산마그네슘으로 건조하고, 녹지 않은 적린을 여과하여 제거하고 유기층을 감압 농축하여 흰색의 결정으로 목적하는 화합물을 얻었다. 목적화합물을 9.05g의 수율(이론치의 96.5%)로 수득하였다.Dissolve 10.0 g (44.8 mmol) of 5H-dibenz [b, e] azepine-6,11-dione in 50 ml of acetic acid, add 1.5 g (48.4 mmol) of red phosphorus, and 15 ml of 57% iodic acid for 18 hours. Stirred at reflux. After cooling to room temperature, 300 ml of ice water in which 7 g of sodium hydrogen sulfite was dissolved was poured into the reaction mixture, stirred, 300 ml of chloroform was added thereto, and then vigorously stirred. The organic layer was separated, washed with an aqueous solution of saturated sodium hydrogen carbonate, It dried with anhydrous magnesium sulfate, the insoluble red phosphorus was filtered out, the organic layer was concentrated under reduced pressure, and the target compound was obtained as white crystal | crystallization. The desired compound was obtained in a yield of 9.05 g (96.5% of theory).

융점 : 200~201℃ Melting Point: 200 ~ 201 ℃

IR cm-1(KBr) : 3190, 3030, 2980, 2910, 1650, 1590, 1570, 1490, 1450, 1440, 1380IR cm -1 (KBr): 3190, 3030, 2980, 2910, 1650, 1590, 1570, 1490, 1450, 1440, 1380

1H-NMR(CDCl3) : δ 3.87(s, 2H), 7.00~7.27(m, 6H), 7.37(t, 1H, J=7.5Hz), 7.86(d, 1H, J=7.7Hz) 8.64(s, 1H) 1 H-NMR (CDCl 3 ): δ 3.87 (s, 2H), 7.00 ~ 7.27 (m, 6H), 7.37 (t, 1H, J = 7.5Hz), 7.86 (d, 1H, J = 7.7Hz) 8.64 (s, 1H)

MASS m/z : 209 (M+), 180 (M+-29)MASS m / z: 209 (M +), 180 (M + -29)

[실시예 2]Example 2

0.6g (2.7mmol)의 5H-디벤즈[b,e]아제핀-6,11-디온을 6.7ml의 초산에 녹인 후 0.33g (10.7mmol)의 적린과 4.0ml의 47% 요오드산을 넣고 19시간동안 환류 교반하였다. 실온까지 방냉 후 1g의 아황산수소나트륨이 용해된 100ml의 얼음물에 반응 혼합물을 붓고 교반 후, 생성된 결정을 여과하고, 얻은 결정을 200ml의 메틸렌클로라이드에 용해시킨 후 녹지 않은 적린은 여과하여 제거하고 농축하여 흰색의 결정으로 목적하는 화합물을 얻었다. 목적화합물을 0.5g의 수율(이론치의 89.0%)로 수득하였다.0.6 g (2.7 mmol) of 5H-dibenz [b, e] azepine-6,11-dione was dissolved in 6.7 ml of acetic acid, followed by 0.33 g (10.7 mmol) of red phosphorus and 4.0 ml of 47% iodine It was stirred at reflux for 19 hours. After cooling to room temperature, the reaction mixture was poured into 100 ml of ice water in which 1 g of sodium bisulfite was dissolved and stirred, and the resulting crystals were filtered. The obtained crystals were dissolved in 200 ml of methylene chloride, and the undissolved red phosphorus was filtered and concentrated. To obtain the desired compound as white crystals. The desired compound was obtained in a yield of 0.5 g (89.0% of theory).

본 발명에 따른 제조방법은 초산을 반응용매로 사용하고 촉매로서 요오드산과 적린을 사용하여 온화한 반응조건에서 반응을 수행하고 용이한 후처리공정을 통하여 높은 수율과 순도로 목적화합물 및 유사 화합물을 제조하는 방법을 제공한다.In the production method according to the present invention, using acetic acid as a reaction solvent, using iodic acid and red phosphorus as a catalyst, the reaction is carried out under mild reaction conditions, and a target compound and a similar compound are prepared in high yield and purity through an easy post-treatment process. Provide a method.

Claims (3)

다음 화학식 2로 표시되는 화합물을 환원제로 요오드산과 적린을 사용하여 환원시켜서 화학식 1로 표시되는 5,11-디히드로-6H-디벤즈[b,e]아제핀-6-온을 제조하는 방법.A method for preparing 5,11-dihydro-6H-dibenz [b, e] azin-6-one represented by Chemical Formula 1 by reducing the compound represented by Chemical Formula 2 using iodic acid and red phosphorus as a reducing agent. [화학식 1][Formula 1] [화학식 2][Formula 2] (삭제)(delete) 제 1항에 있어서, 반응용매로 초산를 사용하는 방법.The method of claim 1, wherein acetic acid is used as a reaction solvent.
KR10-2002-0039111A 2002-07-06 2002-07-06 Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one KR100486320B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-0039111A KR100486320B1 (en) 2002-07-06 2002-07-06 Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0039111A KR100486320B1 (en) 2002-07-06 2002-07-06 Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Publications (2)

Publication Number Publication Date
KR20040004891A KR20040004891A (en) 2004-01-16
KR100486320B1 true KR100486320B1 (en) 2005-04-29

Family

ID=37315283

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0039111A KR100486320B1 (en) 2002-07-06 2002-07-06 Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one

Country Status (1)

Country Link
KR (1) KR100486320B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103130717B (en) * 2011-11-29 2015-04-01 上海博康精细化工有限公司 Preparation method of 2-benzo diazepine anthrone

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056529A (en) * 1975-01-16 1977-11-01 John Wyeth & Brother Limited Dibenzopyrimidoazepines
US20020025956A1 (en) * 1999-06-14 2002-02-28 Kevin Hodgetts 1-azatricyclic-4-benzylpiperazines
KR20030000408A (en) * 2001-06-25 2003-01-06 바이오네스트 주식회사 A Method for the Preparation of 2,6-Morphanthridone, the Intermediate of Epinastine
KR200300408Y1 (en) * 2002-08-24 2003-01-14 장민호 Lighting device for vehicle instrument panel
KR20030021786A (en) * 2001-09-07 2003-03-15 바이오네스트 주식회사 A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine
KR200321786Y1 (en) * 2003-04-26 2003-07-31 김용모 Biological imaging microscope

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4056529A (en) * 1975-01-16 1977-11-01 John Wyeth & Brother Limited Dibenzopyrimidoazepines
US20020025956A1 (en) * 1999-06-14 2002-02-28 Kevin Hodgetts 1-azatricyclic-4-benzylpiperazines
KR20030000408A (en) * 2001-06-25 2003-01-06 바이오네스트 주식회사 A Method for the Preparation of 2,6-Morphanthridone, the Intermediate of Epinastine
KR20030021786A (en) * 2001-09-07 2003-03-15 바이오네스트 주식회사 A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine
KR200300408Y1 (en) * 2002-08-24 2003-01-14 장민호 Lighting device for vehicle instrument panel
KR200321786Y1 (en) * 2003-04-26 2003-07-31 김용모 Biological imaging microscope

Also Published As

Publication number Publication date
KR20040004891A (en) 2004-01-16

Similar Documents

Publication Publication Date Title
JP5000841B2 (en) Method for producing clopidogrel
JP2009029805A (en) Production method of clopidogrel
EP2220064B1 (en) A process for the preparation of (3ar,4s, 6r, 6as)-6-amino-2, 2- dimethyltetrahydro-3ah-cyclopenta[d][1,3]dioxol-4-ol-dibenzoyl-l-tartrate and to products of said process
JPH0314025B2 (en)
JPS6168469A (en) Manufacture of 6-chloro-n-methyl-2,3,4,5-tetrahydro-1h- 3-benzazepine
US5101040A (en) Process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide
KR100486320B1 (en) Preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
JPH0570437A (en) Process for producing 1-carbamoylpyrazol
KR100612779B1 (en) New process for the preparation of chiral glycidylphthalimide in highly optical purity
NO153368B (en) PROCEDURE FOR THE PREPARATION OF 10-OXO-10,11-DIHYDRO-5H-DIBENZ (B, F) -ASEPINE-5-CARBOXAMIDE
US6147215A (en) Process for producing 1-chlorocarbonyl-4-piperidinopiperidine or hydrochloride thereof
KR100654923B1 (en) Process for continuously preparing high purity chiral amide compound
KR101170192B1 (en) One-pot process for producing 1,2-benzisoxazole-3-methanesulfonamide
US20040192919A1 (en) Process for production of highly pure donepezil hydrochloride
US4370500A (en) Compound: d-N-(2-amino-2-phenethyl)-2-methoxyethylamine and process for preparing the same by selective crystallization
JPH0665198A (en) New process for industrially producing 4-chloro-3- sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide
US20030149278A1 (en) Method for preparing (+)-biotine
KR100441348B1 (en) A Method for the Preparation of 6-Morphanthridone, the Intermediate of Epinastine
KR100486316B1 (en) New preparation method of 5,11-dihydro-6H-dibenz[b,e]azepin-6-one
WO1999041214A1 (en) Halogenating agent and process for halogenating hydroxyl group
KR890000522B1 (en) Process for preparing penicillanic acid 1,1-dioxide
JPH0586042A (en) Process for producing 2-mercapto-phenothiazine
KR100898099B1 (en) Process for preparation of Zaltoprofen
KR920003172B1 (en) Process for preparing 2-acet amino tiophen
EP1669347A1 (en) Process for the preparation of 3-¬(4-fluorophenyl) sulfonyl|-2-hydroxy-2-methyl propionic acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee